Gelonghui September 10 丨 Shanwaishan (688410.SH) disclosed an investor relations activity record sheet showing that Shanwaishan Company's domestic sales of continuous blood purification equipment (CRRT) use a combination model of direct sales and distribution, with distribution as the main model. The company's sales are all in a buy-out distribution model, and there are no cases where equipment is launched.

The continuous blood purification line developed by Shanwaishan Company is a special consumable material for the company's SWS-5000 equipment (CRRT) and is a closed system. As the market share of the company's CRRT equipment increases, as well as the increase in operating rate and frequency of use, it will drive a continuous increase in CRRT consumables sales revenue.